Health Canada Approves NeuroCatch™ Brain Assessment System

No comments

Credit: NeuroCatch Inc. (CNW Group/NeuroCatch Inc.)

Register to receive a free U.S. Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices report synopsis and brochure

NeuroCatch, Inc. has recently announced the approval of their NeuroCatch™ Platform for a medical device license as Canada’s first objective and rapid neuro-physiological brain function assessment system. The device assesses neurological function through the measurement of event-related potentials (ERPs). The company claims that the device is cost-effective, easy-to-use and readily accessible.

“NeuroCatch Inc. is proud to receive a Health Canada medical device licence for our objective brain function assessment system and bring this highly significant tool and medical resource directly to clinicians and researchers. This system is based on years of evidence-based science and research completed by our incredible team,” said Kirk Fisher, CEO of NeuroCatch Inc. “Now clinicians and researchers have a readily deployable, rapid and highly accurate system that can help them make objective brain function assessments.”

The NeuroCatch system uses electroencephalogram (EEG) electrodes embedded into a mesh cap, allowing for wireless interfacing with the complementary custom software system. The scan consists of a proprietary auditory stimulus which lasts about six minutes and has been specially designed to evoke desired brain responses.

“We are excited to be the first in Canada to offer the NeuroCatch Platform as a brain function assessment tool for our clients,” said Sonia Brodie, Clinic Enterprise Manager at the Surrey Neuroplasticity Clinic. “As a neuro-rehabilitation therapy clinic focused on clients with neurological conditions, it is extremely valuable to have such a device that our therapists can easily use to objectively and accurately measure brain function.”

The platform then assesses the neuro-physiological state objectively using three key ERPs and the sequence of auditory sensation, basic attention and cognitive processing. Following the analysis, the data is passed and output into a NeuroCatch Platform Report, which can be used by professionals to aid them in patient evaluation.

For Further Information

More on the neurological device market can be found in a series of reports published by iData entitled the U.S. Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices.

iData ResearchHealth Canada Approves NeuroCatch™ Brain Assessment System

Related Posts